13P Efficacy and biomarker exploration of anlotinib plus penpulimab for extensive-stage small-cell lung cancer who failed previous platinum-based chemotherapy: Results from a phase II perspective trial
Yi Zhang(Sun Yat-sen University), Ning Yang(First Affiliated Hospital of Hebei Medical University), Yu Feng(Xiangyang Central Hospital), Mengyu Xiao(Hunan Academy of Traditional Chinese Medicine), Fang Zeng(Hunan Cancer Hospital), Wenjuan Jiang(Hunan Cancer Hospital), Chunhua Zhou(First Affiliated Hospital of Guangzhou Medical University), Bing Zhang(Baylor Genetics), Haiyan Yang(Central South University), Li Liu(Illumina (United States)), Qian Chen(Suzhou Research Institute), Chong Wang(Children's Hospital of Chongqing Medical University), Zhonghua Wang(Shanghai Medical College of Fudan University), Liang Zeng(Hunan Cancer Hospital), Zhifeng Wu(The First People's Hospital of Changde), Yi Xiong(Hunan Cancer Hospital), Jiayu Liang(Shenyang Aerospace University)
Cited by 3
Related Papers
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
|Nature Communications|2016|1.6k